- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03400007
Clinical and Dynamic Floor MRI Evaluation Before and After Prolapse Surgery
Pre- and Postoperative Dynamic Floor MRI in Order to Evaluate the Anatomical and Functional Changes of the Different Pelvic Floor Organs, Before and After Prolapse Surgery.
Pelvic organ prolapsed, associated with defecation disorders and urinary tracts symptoms are common and affect up to 25% of the population, mostly parous women. The pelvic floor must be seen as one entity, with multiple anatomical and physiological interactions between the various compartments (rectum, vagina, uterus and bladder) which are embedded in the same anatomical region. The often complex pathologies of this region should therefore be treated in a multidisciplinary setting.
Besides clinical evaluation, functional dynamic imaging of anorectal and pelvic floor disfunctions has an important role in the diagnosis and management of these disorders. Although the colpocystodefecography is still considered to be the golden standard in imaging this complex anatomical region, there is clearly a need for more precise imaging of the structural details, preferentially without any irradiation. Transperineal ultrasound is an option but the investigators have chosen to evaluate the use of dynamic magnetic resonance imaging. In contrast to colpocystodefecography, dynamic pelvic floor magnetic resonance imaging is an evolving technology and its precise role in functional imaging of the pelvic floor still remains to be determined.
Prolapse surgery is commonly performed and therefore it is important to assess the efficacy of the operations in correcting the anatomical defects and the symptoms associated without creating new, pelvic floor related symptoms. Few studies exist today allowing the assessment of the anatomical changes and symptoms after surgery, through abdominal or perineal approach.
This study will evaluate the reliability of the dynamic pelvic floor imaging, done in a sitting position, compared to colpocystodefecography, done in a sitting position. It will also compare clinical objective and subjective results related to pelvic floor abnormalities with imaging. Finally, it will evaluate the anatomical changes in correlation with the clinical results, organ position and inter-compartments relationships after surgery.
This study will allow to understand and explain some relapses and failures and could lead to an improvement of the indications for surgery and surgical techniques used.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Brussel, Belgium, 1020
- CHU Brugmann
-
Brussels, Belgium
- Chu St Pierre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
All patients who will undergo internal or external rectal prolapse, enterocele or urogenital prolapse surgery in CHU Brugmann and CHU St Pierre.
Exclusion Criteria:
- MRI contra-indications
- Patients with prior pelvic floor surgery
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Prolapse surgery
|
Dynamic floor magnetic resonance imaging (MRI)
Colpocystodefecography (CCD)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
recto-anal angle -relax position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in left lateral decubitus position (141°)
|
6 months post surgery
|
recto-anal angle -retain position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in left lateral decubitus position (163°)
|
6 months post surgery
|
recto-anal angle -push position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in left lateral decubitus position (165°)
|
6 months post surgery
|
recto-anal angle -relax position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in sitting position (141°)
|
6 months post surgery
|
recto-anal angle -retain position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in sitting position (125°)
|
6 months post surgery
|
recto-anal angle -push position
Time Frame: 6 months post surgery
|
Measured by dynamic floor MRI in sitting position (143°)
|
6 months post surgery
|
Dynamic MRI: anterior compartment
Time Frame: 6 months post surgery
|
From the bladder, discrete inferior descent of the pubococcygeal line: max 1/3 (yes/no)
|
6 months post surgery
|
Dynamic MRI: medium compartment
Time Frame: 6 months post surgery
|
Vagina horizontalization (yes/no)
|
6 months post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fecal Incontinence Severity Index (FISI)
Time Frame: 6 months post surgery
|
This is a health tool that describes the severity of different types of incontinence for bowel contents.There are 4 items in the FISI scale with 6 answer choices.
Points are awarded according to the gravity of the symptoms.
The higher the FISI index (which ranges from 0 to 61), the higher the severity of the fecal incontinence.
|
6 months post surgery
|
Constipation scoring system (CCS)
Time Frame: 6 months post surgery
|
Validated questionnaire.
Minimum Score, 0 - Maximum Score, 30
|
6 months post surgery
|
Prolapse Quality of Life (P-QOL) questionnaire
Time Frame: 6 months post surgery
|
Validated questionnaire covering nine domains: general health (1 item), prolapse impact (1 item), role (2 items), physical (2 items) and social limitations (3 items), personal relationships (2 items), emotions (3 items), sleep/energy (2 items), and severity measurement (4 items).
The answers are categorized using a fourpoint Likert scale: "none/not at all," "slightly/a little," "moderately," and "a lot."
A score is calculated for each domain ranging from 0 to 100.
A higher score indicates a greater impairment of quality of life.
|
6 months post surgery
|
Sexual function questionnaire (PISQ-IR)
Time Frame: 6 months post surgery
|
Validated questionnaire.
The PISQ-12 measures three domains: behavioral-emotive (items 1 - 4), physical (items 5 - 9) and partner-related (items 10 - 12).
It is a self-administered questionnaire, and responses are graded on a five-point Likert scale ranging from 0 (always) to 4 (never).
Items 1 - 4 are reversely scored and a total of 48 is the maximum score.
Higher scores indicate better sexual function.
|
6 months post surgery
|
Visual analogic Scale (VAS)
Time Frame: 6 months post surgery
|
The VAS scale (EVA in French) is a straight line of 100 mn length.
One end is the absence of pain, the other end represents unbearable pain.
The patient places a mark between these 2 extremities according to the intensity of his pain at a given time.
|
6 months post surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Katleen Jottard, MD, CHU Brugmann
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUB-prolapse
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prolapse
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, Lille; Centre Hospitalier de La Rochelle; Kremlin-Bicetre... and other collaboratorsRecruitingProlapse; Female | Prolapse Uterovaginal | Prolapse; CervixFrance
-
Rennes University HospitalRecruiting
-
The Methodist Hospital Research InstituteUnknownVaginal Vault Prolapse | Post-Hysterectomy Vaginal Vault Prolapse | Prolapse, VaginalUnited States
-
TriHealth Inc.RecruitingProlapse; Female | Prolapse, Vaginal | Prolapse, UterineUnited States
-
Manchester University NHS Foundation TrustRecruitingProlapse; Female | Prolapse, VaginalUnited Kingdom
-
National Taiwan University HospitalCompletedVault Prolapse, Vaginal
-
Ain Shams UniversityCompletedUterovaginal and Vaginal Vault ProlapseEgypt
-
Kaiser PermanenteMassachusetts General HospitalUnknownProlapse of Vaginal Vault After HysterectomyUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedVaginal ProlapseFrance
-
Mayo ClinicCompletedPelvic Organ Prolapse | Uterine Prolapse | Vaginal Vault Prolapse | Pelvic Floor ProlapseUnited States
Clinical Trials on Dynamic floor magnetic resonance imaging
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknownPelvic Organ Prolapse | Normal Pelvic FloorChina
-
Roswell Park Cancer InstituteWithdrawn
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Tumors Metastatic to BrainUnited States
-
Cancer Clinical Trials Unit, ScotlandCompletedBreast CancerUnited Kingdom
-
University of Texas Southwestern Medical CenterWithdrawn
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMetastatic Malignant Neoplasm in the Brain | Invasive Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOvarian Carcinoma | Malignant Ovarian NeoplasmUnited States